Express Pharma November 2023
India's Foremost Pharma & Biotech Magazine ~ Beyond Manufacturing: Broadening Horizons of CDMOS
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon at No. 8 in Science Magazine’s list of best employers in biotech and pharma
Biocon has featured on the Science Top Employers list of the world’s pre-eminent pharma, biotech, and biopharma employers for 11…
Zydus acquires LiqMeds Group
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026 depending on achievement of certain…
Aragen setting up a $ 30mn bio-manufacturing site in Bengaluru
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
FDA rejection to delay Lebrikizumab chances to enter atopic dermatitis market: GlobalData
GlobalData currently expects Lilly to resubmit lebrikizumab’s BLA in Q4 2023
Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report
The quarter saw 26 deals totalling $2.7 billion, with a 32 per cent decline in deal volumes compared to Q3 2022
Suven announces positive topline results from Phase-2 study of Samelisant for EDS in adult…
The study met primary endpoint, with Samelisant demonstrating statistically significant and clinically meaningful reduction in EDS…
Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData
Out of the top 20 companies, nine saw their market capitalisation surge by more than 10 per cent, with significant gains achieved…
Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India
The drug will be marketed by Sun Pharma under the brand name RYTSTAT. Zydus continues to market the drug under the brand name…
SPARC completes enrolment in PROSEEK, Phase 2 study of Vodobatinib in early Parkinson’s disease
506 patients completed enrolment across 84 sites in the US, Europe and India